Delivery Order SPE2DB22D2206-SPE2DB24FKH74

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 80 mg/0.8 ml syringes. The contract has a ceiling value of $2,257.11 and is a firm fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Enoxaparin 100 mg/mL syringes. The $1,995.34 Delivery Order contract is a Firm Fixed Price award, with an ultimate completion date of June 10, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,186.72, is for the delivery of Enoxaparin 80 mg/0.8 ml syringes. This is a firm-fixed-price delivery order with a completion date of January 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,079.59 contract is for the delivery of ENOXAPARIN 100 MG/ML SYRINGEML, a critical specialty medication. It is a firm fixed-price delivery order, with an ultimate completion date of September 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to...
This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Enoxaparin 80 mg/0.8 mL syringes, a critical care medication. The contract has a ceiling value of $1,032.12 and an ultimate completion date of September 11, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ENOXAPARIN 60 MG/0.6 ML SYR 0.6ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,491.42 and a completion date of May 27, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.98 firm fixed-price delivery order is for the supply of 4566556101 - ENOXAPARIN 120 MG/0.8 ML SYR 0.8ML, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1X6, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565713260 - ENOXAPARIN 40 MG/0.4 ML SYR 0.4ML, with a ceiling value of $3,603.84 and a completion date of September 9, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,269.90 firm fixed price delivery order is for the supply of 80 mg/0.8 mL enoxaparin syringes. The award is not set aside and has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a larger $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2025 to provide a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKH74
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 40 mg/0.4 ml syringes. The firm-fixed-price, delivery order contract has a ceiling value of $3,396.94 and a performance period ending on September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 12/13/24, 9:23 AM